Today on DrugResearcher.com
 
Merck KGaA disappointed by Parkinson's drug results

Pfizer expands biologics R&D

Amgen expounds IL-17 potential as arthritis target

Novartis turns its back on India

Drugs moving into the clinic: 25

 
   
Related Industry News
 
FDA embraces outsourcing

Pharma packaging goes futuristic

GPC feeling the pressure

Symyx expands lab automation tools

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Thursday 23 August 2007 Forward to a colleague

Product Overview

PharmatestPre-Clinical Contract Research - Free Download

Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here


Access Full Stories



Merck KGaA disappointed by Parkinson's drug results
Newron Pharmaceuticals and its partner Merck KGaA suffered a disappointment yesterday, when their investigational Parkinson's disease drug failed a pivotal clinical trial... Read


Pfizer expands biologics R&D
Pfizer is breaking ground on a $50m expansion of its biologics pilot plant in Chesterfield, at a time when the drug giant is cutting back in other business areas... Read


Amgen expounds IL-17 potential as arthritis target
Amgen are rushing to discover how interleukin-17 causes inflammation and bone destruction in rheumatoid arthritis, as it could provide a valuable new therapeutic target... Read


Novartis turns its back on India
Novartis is to pull millions of planned investment dollars out of India in reaction to intellectual property (IP) fears. The decision may leave China as the cat that got the cream... Read


Drugs moving into the clinic: 25
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


All News Headlines for:
August | July | June

deltaDOTTechnical / White paper

deltaDOT label free analysis of biomolecules

Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here
Related Industry News



FDA embraces outsourcing
The US Food and Drug Administration (FDA) is following the growing pharma industry trend by embracing outsourcing as part of a cost-saving drive - a move that is attracting strong opposition... Read


Pharma packaging goes futuristic
A France-based packaging solutions company plans to launch heat-shrink labels with integrated holograms into the pharma industry, in what it believes will be the next big counterfeiting solution for the sector... Read


GPC feeling the pressure
Just weeks after disappointing news regarding its potential billion-dollar drug satraplatin was swiftly followed by a class action lawsuit against the company, GPC Biotech has announced plans to cut 15 per cent... Read


Symyx expands lab automation tools
Symyx Technologies has released a machine designed to automate the sample preparation stage of active pharmaceutical ingredient (API) solubility experiments, saving researchers valuable time... Read

Weekly Comment

No lack of innovation in pharma, says Wyeth

The often cited decline in R&D productivity and dwindling innovation within the pharma industry is actually a thing of the past, according to Wyeth's head of business development. Read



BionasSponsored Message

Live cell-based assay with Bionas® 2500 analyzing system

Bionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds... Click Here

Previous Headlines



Merck-Frosst pushing mass spectroscopy into overdrive
Merck-Frosst Canada is pushing the limits of mass spectroscopy (MS), hoping to speed it up enough to achieve true high-throughput screening of difficult drug targets... Read


Biogen Idec aiming for biologic Alzheimer's drug
A team of scientists at Biogen Idec have unveiled preclinical data for a potential protein therapeutic to treat Alzheimer's, a disease normally only attacked using small molecules due to delivery issues... Read


Award for preclinical services firm
Domainex, a London- and Cambridge-based preclinical services firm has won an industry award for its bottleneck-breaking genomics technology... Read


Applied Biosystems expanding genotyping access
Through a new service partnership, Applied Biosystems is helping scientists study genetic variations - even if they can't access or afford the necessary lab equipment... Read


Amgen's approach to selectivity predictions
Amgen has outlined how it uses computer models to predict the selectivity of small molecule drugs... Read

Technical / White Papers, Case studies, Web casts
deltaDOT label free analysis of biomolecules - Technical / White paper



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com